CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

Data presented at ASH suggest that the CRISPR therapy could provide a one-time functional cure in children as young as 5 ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

India's GenAI infrastructure is being built, but can a public-private partnership outpace the trillion-dollar budgets of US ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.

The pre-Series A funding round was led by Spectrum Impact with participation from the founders and existing investors including Vijay Alreja Family Office.

CrisprBits has secured $3 Mn (INR 26.8 Cr) in a pre-Series A funding round led by Spectrum Impact and Rajendra Gogri's family ...